Free Republic 4th Quarter Fundraising Target: $85,000 Receipts & Pledges to-date: $71,206
83%  
Woo hoo!! And now less than $13.8k to go!! We can do this. Thank you all very much!!

Keyword: singulair

Brevity: Headers | « Text »
  • Asthma Drug Label to Include Psychiatric Risk

    07/21/2009 9:08:43 AM PDT · by neverdem · 12 replies · 489+ views
    Family Practice News ^ | 1 July 2009 | LORINDA BULLOCK
    The Food and Drug Administration last month called on manufacturers of leukotriene inhibitors to include safety precautions on their drug's labeling, because of reports of neuropsychiatric events in patients taking these drugs. The FDA said the reported neuropsychiatric events included cases of agitation, aggression, anxiety, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal ideation and behavior, and tremor in patients using montelukast (Singulair), zafirlukast (Accolate), and zileuton (Zyflo, Zyflo CR). Manufacturers of these drugs were asked to submit all available clinical trial data for these products for the safety review that concluded in April. In its review, the FDA...
  • New Jersey Takes The Lead In Confronting Autism

    12/29/2002 7:53:16 PM PST · by Incorrigible · 36 replies · 5,565+ views
    Newark Star Ledger ^ | 12/29/2002 | Carol Ann Campbell
    NEW JERSEY TAKES LEAD IN CONFRONTING AUTISM Researchers are challenging assumptions about the disorder Sunday, December 29, 2002 BY CAROL ANN CAMPBELL Star-Ledger Staff [New Jersey] -- Catherine Wersinger remembered the day she held a cup of juice in front of her son Peter, then 2 1/2 years old and diagnosed with autism. "Say juice, Peter," she called out. "Juice. See, juice! Juice! Just say, 'juh' 'juh!' Can you say, 'juh'?" Her bright-eyed boy stood stone-faced. He could not say one word. Not mama. Not dada. Not juice. Today Peter is among the first autistic children being treated by a...